8VC Names Karen White as Executive Partner
Karen has been a driving force behind several multi-billion-dollar companies, and brings her extraordinary history of innovation, transformation, and hypergrowth to 8VC. She will work side by side with CEOs and founders to help scale their businesses and evolve their strategies and execution, building on a decade as a key advisor to both 8VC and portfolio companies including Addepar and OpenGov. From the 8VC platform, Karen will also co-found and lead a new technology company, to be announced at a later date.
According to 8VC General Partner
As Karen notes, "The scale of ambition and pure intellectual horsepower at 8VC blows me away. I have enormous respect for Joe and what he's built here. It's a different kind of firm and is surrounded by the most engaged and active network I've ever seen. I could not be more excited to be working closely with our entrepreneurs to help them realize their ambitions, and to be co-founding a new company from within 8VC."
Karen was formerly CEO at RMS. Under her leadership, RMS launched its innovative risk platform and became the world's leading catastrophic risk tech company, leading to its acquisition by Moody's for
Prior to RMS, Karen was President and COO at Addepar, the pioneering investment management software company founded by
From 1993-2000, Karen worked for CEO
About 8VC:
8VC is a leading technology investment firm, backing visionary teams and industry-transforming companies. The partners have an extensive track record as founders, builders, and operators of companies including Palantir, Addepar, Resilience, and OpenGov. 8VC manages over
View original content to download multimedia:https://www.prnewswire.com/news-releases/8vc-names-karen-white-as-executive-partner-302088217.html
SOURCE 8VC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
- Allegheny Health Network's Biomarker Moonshot Cancer Research Program Marks Five-Year Milestone, Enrolling More Than 11,000 Patients Across All Cancer Types
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Larry Ellison, Definitive Agreement, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share